Winston & Strawn LLP advises a diverse client base consisting of pharmaceuticals, biologics and medical devices producers on matters ranging from patent, product liability and broader commercial litigation, to M&As and private equity investments in the sector. Leading the team is Washington DC’s Reed Stephens, a specialist in FCA and Anti-Kickback proceedings, and with further expertise in Medicare and Medicaid reimbursement proceedings. Chicago-based George Lombardi offers extensive experience litigating patent disputes. May 2023 saw the practice reinforced by the arrival of a three-partner group from Reed Smith LLP, with government contracts lawyers Lawrence Block, Elizabeth Leavy and Lawrence Sher arriving in the capital.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Abbott Laboratories
- Alphatec Holdings
- Bayer
- Cresco Labs
- Corning Incorporated
- Estrella Biopharma, Inc.
- Fresenius Kabi USA
- Hikma Pharmaceuticals
- Intuitive Surgical
- Lupin Limited
Highlight-Mandate
- Represented Corning in a month-long patent infringement and trade secrets trial related to cell-culturing technology.
- Representing Hikma Pharmaceuticals in opioid litigation brought by the state of Arkansas by successfully arguing failure to state a claim against our client.
- Represented a MIT professor against false research misconduct charges, publicly clearing his name in connection with an internal investigation that lasted more than three years.
Anwält*innen
Praxisleitung
Reed Stephens
Weitere Kernanwält*innen
George Lombardi; Lawrence Block; Elizabeth Leavy; Lawrence Sher